Skip to content
healthcare.dev

deferasirox

NDC 62756-569, deferasirox, tablet, for suspension, from Sun Pharmaceutical Industries, Inc..

Product NDC
62756-569
Status
Listed
Labeler
Sun Pharmaceutical Industries, Inc.
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209782
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62756-569 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFERASIROX250 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]

Package NDCNDC-11Package
62756-569-836275605698330 TABLET, FOR SUSPENSION in 1 BOTTLE (62756-569-83)
62756-569-866275605698660 TABLET, FOR SUSPENSION in 1 BOTTLE (62756-569-86)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4a2e1bd2-9f3a-40ec-94a2-bc76350d6d4b

Use it

Look up 62756-569 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62756-569 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62756-569. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.